Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (Q73409370)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2000

Language	Label	Description	Also known as
English	Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer	scientific article published on 01 January 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jeffrey S. Miller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

L J Burns

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D J Weisdorf

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T E DeFor

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T L Repka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K M Ogle

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Hummer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Experimental Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

96-103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia--a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2899%2900129-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-472X(99)00129-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10658681%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73409370&oldid=2223303245"